BSI 111
Alternative Names: BSI-111Latest Information Update: 15 Jun 2024
At a glance
- Originator Biosion
- Class Antineoplastics; Immunotherapies; Monoclonal antibodies
- Mechanism of Action IgG receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer